Circulating platelet-derived microparticles and endothelium-derived microparticles may be a potential cause of microthrombosis in patients with osteonecrosis of the femoral head

Thrombosis Research

Volumn 123, Issue 2, 2008, Pages 367-373

  Kang, Pengde ^a   Shen, Bin ^a   Yang, Jing ^a   Pei, Fuxing ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Endothelial cell; Femoral head; Microparticles; Osteonecrosis; Platelet

Indexed keywords

C REACTIVE PROTEIN; CD31 ANTIGEN; CD42A PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; PADGEM PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE NECROSIS; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL MICROPARTICLE; FEMALE; FEMUR HEAD; FIBROSIS; FLOW CYTOMETRY; HUMAN; HYPERCOAGULABILITY; MALE; MICROTHROMBUS; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; THROMBOSIS; ULTRACENTRIFUGATION;

ADULT; ANTIGENS, CD31; BLOOD PLATELETS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; E-SELECTIN; ENDOTHELIAL CELLS; FEMALE; FEMUR HEAD NECROSIS; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PARTICLE SIZE; PLATELET COUNT; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; RISK FACTORS; THROMBOSIS;

EID: 55549115988     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.04.001     Document Type: Article

References (26)

1. Lieberman J.R., Berry D.J., Mont M.A., Aaron R.K., Callaghan J.J., Rayadhaksha A., et al. Osteonecrosis of the hip: management in the twenty-first century. J Bone Joint Surg Am 84 (2002) 834-853
2. Aaron RK, Clombor DM. Coagulations and osteonecrosis. Curr Opion Orthop 412:370-83.
3. Korompilias A.V., Ortel T.L., and Urbaniak J.R. Coagulation abnormalities in patient with hip osteonecrosis. Orthop Clin North Am 35 (2001) 265-271
4. Glueck C.J., Freiberg R.A., and Wang P. Role of thrombosis in osteonecrosis. Curr Heamatol Rep 2 (2003) 417-422
5. Wang C., Mody M., Herst R., and Sher G. Flow cytometric analysis of platelet function in stored platelet concentrates. Transfus Sci 20 (1999) 128-139
6. Dachary P.J., Fieyssinet J.M., Pasquet J.M., Carron J.C., and Nurden A.T. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups. Blood 31 (1993) 2554-2565
7. Nomura S. Function and clinical significance of platelet-derived microparticles. Int J Heamatol 74 (2001) 397-404
8. Sijander P., Carpen O., and Lassila R. Platelet-derived microparticles associate with fibrin during thrombosis. Blood 87 (1996) 4651-4663
9. Barry O.P., Pratico D., Savani R.C., and FitzGerald G.A. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Incest 102 (1998) 136-144
10. Mustrard J.F., and Packham M.A. Platelets and diabetics mellitus. N Engl J Med 311 (1984) 665-666
11. Ogata N., Imaizumi M., Nomura S., Shozu A., Arichi M., Matsuoka M., et al. Increased levels of platelet-derived microparticles in patients with diabetic retinopathy. Diabetic Res Clin Pract 68 (2005) 193-201
12. Ando M., Iwata A., Ozeki Y., Tsuchiya K., Akiba T., and Nihei H. Circulating platelet-derived microparticles with precoagulant activity may be a potential cause of thrombosis in uremic patients. Inter. Soc. Nephrol 62 (2002) 1757-1763
13. Brogan P.A., Shah V., Brachet C., Harnden A., Mant D., Klein N., et al. Endothelial and platelet microparticles on vasculitis of the young. Arthritis Rheumatism 50 (2004) 927-936
14. Jimenez J.J., Jy W., Mauro L.M., Horstman L.L., and Ahn Y.S. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease. Br J Heamatol 112 (2001) 81-90
15. Tedgui A., and Mallat Z. Apoptosis as a determinant of arthrothrombosis. Thromb Heamost 86 (2001) 420-426
16. Minagar A., Jy W., Jimenez J.J., Sheremata W.A., Mauro L.M., and Mao W.W. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 56 (2001) 1319-1324
17. Morel O., Toti F., Hugel B., and Freyssinet J.M. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr. Opin. Hematol. 11 (2004) 156-164
18. Pirro M., Schillaci G., Paltriccia R., Bagaglia F., Menecali C., Mannarino M., et al. Increased ratio of CD31+/CD42-microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia. Arterioscler Thromb Vasc Biol 26 (2006) 1-6
19. Ficat R.P. Idiopathic bone necrosis of the femoral head: early diagnosis and treatment. J Bone Joint Surg Br 67 (1985) 3-9
20. Markel D.C., Miskovsky C., Sculco T.P., Pellicci P.M., and Salvati E.A. Core decompression for osteonecrosis of the femoral head. Clin Orthop Relat Res 323 (1996) 226-233
21. Diamant M., Tushuizen M.E., Sturk A., and Nieuwland R. Cellular microparticles: new platers in the field of vascular disease?. Eur J Clin Invest 34 (2004) 392-401
22. VanWijk M.J., VanBavel E., Sturk A., and Nieuwland A.S. Microparticles in cardiovascular diseases. Cardiovasc Res 59 (2003) 277-287
23. Berckmans R.J., Nieuwland R., Böing A.N., Romijin F.P., and Hack C.E. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Heamost 85 (2001) 639-646
24. Gikbert E., Sims P.J., and Wiedmer T. Platelet-derived microparticles express high affinity receptors for factors VIII. J Biol Chem 266 (1991) 17261-17268
25. Tramontano A.F., O'Leary J., Black A.D., Muniyappa R., Cutain M.V., and Ei-Sherif N. Statin decreases endothelial microparticle release from human coronary artery endothelial cells: implication for the Rho-kinase pathyway. Biochem Biophys Res Commun 320 (2004) 34-38
26. Sommeijer D.W., Joop K., Leyte A., Reitsma P.H., and ten Cate H. Prevastatin reduces fibrinogen receptor gpIIIa on platelet-derived microparticles in patients with type 2 diabetes. J Thromb Haemost 3 (2005) 1168-1171